We design our models to be modular and easy to develop/maintain. Our existing models can be expanded to incorporate new biology and to predict the efficacy of novel drugs.
- Will a compound be efficacious for a specific indication?
- What target engagement is required for the compound to be efficacious?
- Will a developed compound be successful in another indication?
- Would a combination approach improve efficacy?